B7-H3-CAR T Cells for Pediatric CNS Tumors
Conditions: Central Nervous System Neoplasms; Atypical Teratoid/Rhabdoid Tumor; Diffuse Midline Glioma, H3 K27M-Mutant; Ependymoma; High Grade Glioma; Glioblastoma; Medulloblastoma Intervention: Drug: B7-H3-CAR T cells Sponsor: St. Jude Children's Research Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain Tumor | Children | Ependymoma | Glioma | Hospitals | Medulloblastoma | Pediatrics | Research